All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What is the role of genetic classification in the diagnosis of DLBCL?

During the 16th International Conference on Malignant Lymphoma (16-ICML), the Lymphoma Hub spoke with Björn Chapuy, Universitätsmedizin Göttingen, Göttingen, DE, and Leticia Quintanilla-Martinez de Fend, University Hospital Tübingen, Tübingen, DE. We asked, What is the role of genetic classification in the diagnosis of diffuse large B-cell lymphoma (DLBCL)?

What is the role of genetic classification in the diagnosis of DLBCL?

Chapuy and de Fend begin by discussing the role of genetic classification and heterogeneity in DLBCL and explore the current obstacle of how to utilize this in routine diagnostics. They go on to highlight the need for clinical trials, and Chapuy outlines a novel clinical trial presented at ICML. Finally, they recap the journey from refining molecular understanding to clinical decision-making.

 

Share: